Sambi, M., Samuel, V., Qorri, B., Haq, S., Burov, S. V., Markvicheva, E., . . . Szewczuk, M. R. (2020). A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Drug Des Devel Ther.
Citação norma ChicagoSambi, Manpreet, Vanessa Samuel, Bessi Qorri, Sabah Haq, Sergey V. Burov, Elena Markvicheva, William Harless, and Myron R. Szewczuk. "A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer." Drug Des Devel Ther 2020.
MLA CitationSambi, Manpreet, et al. "A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer." Drug Des Devel Ther 2020.